Pfizer is suing Johnson & Johnson, saying it prevented uptake of cheaper Remicade rival By: MarketWatch September 20, 2017 at 11:55 AM EDT In an antitrust lawsuit, Pfizer alleged that Johnson & Johnson contracts prevented sales of Pfizer’s Inflectra. Read More >> Related Stocks: Johnson & Johnson Pfizer